{
    "id": 26669,
    "fullName": "KMT2A - ELL",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KMT2A-ELL results from the fusion of KMT2A (MLL) and ELL, resulting in the transformation of primary myeloid progenitor cells, which eventually leads to acute myeloid leukemia in mouse models (PMID: 10995463).",
            "references": [
                {
                    "id": 9251,
                    "pubMedId": 10995463,
                    "title": "Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10995463"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4297,
        "geneSymbol": "KMT2A",
        "terms": [
            "KMT2A",
            "ALL-1",
            "CXXC7",
            "HRX",
            "HTRX1",
            "MLL",
            "MLL1",
            "MLL1A",
            "TRX1",
            "WDSTS"
        ]
    },
    "variant": "KMT2A - ELL",
    "createDate": "06/30/2017",
    "updateDate": "06/30/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 8178,
                "geneSymbol": "ELL",
                "terms": [
                    "ELL",
                    "C19orf17",
                    "ELL1",
                    "MEN",
                    "PPP1R68"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 11380,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, I-BET151 and SGC0946 synergistically inhibited proliferation of patient-derived acute myeloid leukemia cells harboring KMT2A-ELL in culture (PMID: 27294782).",
            "molecularProfile": {
                "id": 27964,
                "profileName": "KMT2A - ELL"
            },
            "therapy": {
                "id": 5966,
                "therapyName": "I-BET151 + SGC0946",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9271,
                    "pubMedId": 27294782,
                    "title": "Functional interdependence of BRD4 and DOT1L in MLL leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27294782"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27964,
            "profileName": "KMT2A - ELL",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}